About Us
Our guiding mission is to identify and investigate cellular and molecular mechanisms that cause and control inflammation and to relate these findings to human health and disease.
We are interdisciplinary in nature; by bringing together different disciplines, we will accelerate our understanding of the common as well as the unique mechanisms that contribute to inflammation-related pathologies.
OMass Therapeutics is a biotechnology company based in Oxford discovering medicines against highly- validated target ecosystems, such as membrane proteins or intracellular complexes. The company’s unique OdyssION™ technology platform comprises novel biochemistry techniques, next-generation native mass spectrometry, and custom chemistry. OMass is advancing a pipeline of small molecule therapeutics in rare diseases and immunological conditions, that target solute carriers, complex-bound proteins, and GPCRs.
Constructive Bio is a VC-backed biotechnology startup based in Whittlesford, Cambridge. Our unique technology turns living cells into biofactories, creating sustainable new materials and therapeutics. With full control of the genetic sequence and code, we are exploring chemical space previously unreached by natural biology.
Who are we?
BioLizard (“The Lizards”) is a leading bioinformatics consultancy that partners with biotech and pharma organizations to bridge biology, data, and AI. Our mission is to unlock insights that accelerate scientific innovation and clinical translation.
BioLizard (“The Lizards”) is a rapidly growing bioinformatics and data science consultancy that helps biotech and pharma organizations transform complex biological data into actionable insights. We combine deep biological expertise with state-of-the-art computational methods to accelerate drug discovery, biomarker development, and translational research.
Who are we?
BioLizard is a growing scale-up company providing bioinformatics and software engineering solutions for customers in biotech, pharma and academia. Typically, a lizard adjusts to its surroundings and that is exactly what we do. At BioLizard we adapt to our customers’ data environment! The research field is rapidly becoming more data-driven. We strive towards offering state-of-the-art bioinformatics, software development and machine learning solutions to help solve our customers’ biological questions.
Sandwich, UK - 11 December 2025: Particology, a specialist particle science company based at science and business hub Discovery Park, has been selected for an £8.2M Government-funded research consortium to make the manufacture of medicines more efficient and sustainable.
The three-and-a-half year research project is part of Innovate UK’s £54M Sustainable Medicines Manufacturing Innovation Programme and is one of eight “Grand Challenge” projects to develop and demonstrate novel technologies for greener, more efficient medicines manufacturing.
Location: Ghent (Flexible, with at minimum once a month travel to HQ in Ghent) Full-time/Part-time
Who are we?
Who we are:
Life, Reimagined
Constructive Bio is a VC-backed biotechnology startup based in Whittlesford, Cambridge. Our unique technology turns living cells into biofactories, creating sustainable new materials and therapeutics. With full control of the genetic sequence and code, we are exploring chemical space previously unreached by natural biology.
o2h Discovery is a full-service Contract Research Organisation with R&D sites in Ahmedabad, India, and Cambridge, UK. With over 800 scientists and support staff, we’ve spent two decades partnering with biotech and pharmaceutical companies to advance discovery programmes across the globe.